N-Ethyl-Ketamine: Research Chemical Profile, Uses and Safety Information

N-Ethyl-Ketamine is a ketamine related chemical compound that has been found and reported in scientific and forensic research. It is also known as N-Ethylnorketamine (NENK), ethketamine. It is registered in chemical databases with the molecular formula C14H18ClNO (CAS registry number 1354634-10-8).

Research into this compound is still limited, so scientists continue to investigate its chemical properties, pharmacology, metabolism and potential risks. It should therefore be confused with a prescription drug that is approved.

What Is NEK (N-Ethyl-Ketamine)?

N-Ethyl-Ketamine is an arylcyclohexylamine that is structurally related to ketamine. Its chemical name is 2-(2-chlorophenyl)-2-(ethylamino)cyclohexan-1-one. PubChem lists N-Ethylnorketamine as one of its accepted names.

N-Ethyl-Ketamine is not an approved pharmaceutical product and there is no established therapeutic dosing standard or sufficiently established safety profile for routine human use. Therefore, information on the Internet may not be complete or accurate.

What does N-Ethyl-Ketamine do?

The NMDA receptor is important for glutamate signalling in the central nervous system and ketamine and related compounds have been extensively investigated.

These substances are described in the studies of related arylcyclohexylamines as non-competitive NMDA receptor antagonists. However, there is much less information available to researchers on the precise pharmacological profile and clinical effects of the individual newer compounds.

Thus, researchers should not presume that N-Ethyl-Ketamine will have similar effects or safety profiles as pharmaceutical ketamine.

Scientific Interest and Research Uses

Scientists have studied N-Ethylnorketamine and related compounds to determine how modifications to the chemical structure influence the activity of NMDA receptors and other neurologic pathways.

An experimental study in 2019 investigated N-Ethylnorketamine hydrochloride and other compounds associated with ketamine. The authors investigated receptor activity and behavioural effects in animal models. Importantly, these experimental results do not establish safety or efficacy in humans.

New psychoactive substances related to ketamine are also studied with the help of analytical chemistry and toxicology. The work can help labs identify compounds in biological samples and understand their metabolites.

Safety Information:

Safety is still a major concern, however, as there is limited human data available on N-Ethyl-Ketamine. The effects of new psychoactive substances are often unpredictable especially when purity, concentration or identity are unknown.

There have also been severe intoxication cases related to ketamine-type related substances. A 2024 toxicological case report of the related compound deschloro-N-ethylketamine described loss of consciousness requiring intensive-care evaluation in a multi-substance case.

N-Ethyl-Ketamine must therefore not be considered as a proven therapeutic medicine.

N-Ethyl-Ketamine and Ketamine

The two compounds should not be automatically regarded as interchangeable despite their related structures.

Ketamine has well established medical uses in controlled settings, whereas N-Ethyl-Ketamine is a much less characterised research compound. Hence, information about ketamine should not be assumed to apply to safety, efficacy, or proper medical use of N-Ethyl-Ketamine.

Summary

N-Ethyl-Ketamine is a research chemical of the Ketamine family that has attracted scientific and forensic attention. The molecular framework, receptor activity, metabolism and toxicological profile are still under investigation. But there is still not enough evidence available to prove it as a safe or approved treatment.

If you are researching this compound, you should consult reliable scientific sources, analytical data, and regulatory status, not anecdotal reports or unsubstantiated product claims.